Company intelligence / Profile preview

Beijing Changping Technology Innodevelop Group

Beijing, Beijing, China

Ownership: Private
Development stage: Other

Overview

Beijing Changping Technology Innodevelop Group is a government-owned industrial investment and operation platform, particularly focused on building and operating biomedicine, pharmaceutical industry chains, and technology parks in Changping District, Beijing; it also performs direct and fund investments in innovative biotech and healthcare companies.

Industry: Investors

Partnerships

Origin Agritech (joint biotech seed venture, R&D/IP development, asset contribution)Qi Biodesign (equity investment in genome editing technology company)GeneQuantum Healthcare (investment via Changjinboya fund)

Beyond the preview

Go deeper on Beijing Changping Technology Innodevelop Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Beijing Changping Technology Innodevelop Group.

Explore the full profile